The effect of food on the pharmacokinetics of Sutetinib maleate capsule, an irreversible EGFR tyrosine kinase inhibitor, in healthy Chinese subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect of food on the pharmacokinetics of Sutetinib maleate capsule, an irreversible EGFR tyrosine kinase inhibitor, in healthy Chinese subjects

Published:2024-04-11 Issue:3 Volume:42 Page:289-298
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Cao Bei,Ma Tingting,Zhang Yuqiang,Huang Lei,Lin Hui,Jiang Huanhuan,Zhao Yu,Geng Yan,Yang Yuanxun,Cao Sumin,Li Juan

Funder

Funding for Clinical Trials from Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

Natural Science Foundation of Nanjing University of Chinese Medicine

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10637-024-01436-0.pdf

Reference38 articles.

1. Leiter A, Veluswamy RR, Wisnivesky JP (2023) The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol 20:624–639. https://doi.org/10.1038/s41571-023-00798-3

2. Li C, Lei S, Ding L, Xu Y, Wu X, Wang H, Zhang Z, Gao T et al (2023) Global burden and trends of lung cancer incidence and mortality. Chin Med J (Engl) 136:1583–1590. https://doi.org/10.1097/CM9.0000000000002529

3. Sun H, Zhang H, Cai H, Yuan W, Wang F, Jiang Y, Gu X, Kang Z et al (2023) Burden of Lung Cancer in China, 1990–2019: findings from the global burden of Disease Study 2019. Cancer Control 30:10732748231198749. https://doi.org/10.1177/10732748231198749

4. Duma N, Santana-Davila R, Molina JR (2019) Non-small Cell Lung Cancer: Epidemiology, Screening, diagnosis, and treatment. Mayo Clin Proc 94:1623–1640. https://doi.org/10.1016/j.mayocp.2019.01.013

5. Wang M, Herbst RS, Boshoff C (2021) Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med 27:1345–1356. https://doi.org/10.1038/s41591-021-01450-2

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3